Evidence map›Paper›PMID 29210603›Full record

ArticleJournal of biomolecular structure & dynamics2018

An unexpected switch in peptide binding mode: from simulation to substrate specificity.

Ursula Kahler, Julian E Fuchs, Peter Goettig, Klaus R Liedl

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Drug Discovery Strategies for Kallikrein-Related Peptidases.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Gaussian accelerated molecular dynamics (GaMD): principles and applications.Wiley interdisciplinary reviews. Computational molecular science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ursula Kahlera Faculty of Chemistry and Pharmacy, Institute of General, Inorganic and Theoretical Chemistry , University Innsbruck , Innrain 82, Innsbruck A-6020 , Austria.
Julian E Fuchsa Faculty of Chemistry and Pharmacy, Institute of General, Inorganic and Theoretical Chemistry , University Innsbruck , Innrain 82, Innsbruck A-6020 , Austria.
Peter Goettigb Division of Structural Biology, Department of Molecular Biology , University of Salzburg , Billrothstrasse 11, Salzburg A-5020 , Austria.
Klaus R Liedla Faculty of Chemistry and Pharmacy, Institute of General, Inorganic and Theoretical Chemistry , University Innsbruck , Innrain 82, Innsbruck A-6020 , Austria.
Universität Innsbruck · ATUniversity of Salzburg · AT

Funding

Austrian Science Fund FWF P 23051Austrian Science Fund FWF P 26997
6 · The paper itself

Abstract

A ten microsecond molecular dynamics simulation of a kallikrein-related peptidase 7 peptide complex revealed an unexpected change in binding mode. After more than two microseconds unrestrained sampling we observe a spontaneous transition of the binding pose including a 180° rotation around the P1 residue. Subsequently, the substrate peptide occupies the prime side region rather than the cognate non-prime side in a stable conformation. We characterize the unexpected binding mode in terms of contacts, solvent-accessible surface area, molecular interactions and energetic properties. We compare the new pose to inhibitor-bound structures of kallikreins with occupied prime side and find that a similar orientation is adopted. Finally, we apply in silico mutagenesis based on the alternative peptide binding position to explore the prime side specificity of kallikrein-related peptidase 7 and compare it to available experimental data. Our study provides the first microsecond time scale simulation data on a kallikrein protease and shows previously unexplored prime side interactions. Therefore, we expect our study to advance the rational design of inhibitors targeting kallikrein-related peptidase 7, an emerging drug target involved in several skin diseases as well as cancer.

Indexed as

Molecular Dynamics SimulationAmino Acid Chloromethyl KetonesCatalytic DomainHumansKallikreinsKineticsLigandsOligopeptidesProtease InhibitorsProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein Interaction Domains and MotifsSubstrate SpecificityThermodynamicsAmino Acid Chloromethyl KetonesKallikreinsKLK7 protein, humanLigandsOligopeptidesProtease Inhibitorssuccinyl-alanylalanyl-prolyl-phenylalanine chloromethylketonechymotrypsin-like serine proteasedrug designin silico mutationpeptide recognitionspecificity subsites

Identifiers

PMID29210603
PMCPMC6334781
OpenAlexW2771072728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.